Dual-vessel intervention treatment for massive hemoptysis caused by lung cavitary lesions

Yang, Qiuhong; Luo, Lin; Wei, Hailong; Yi, Qun; Luo, Wei

doi:10.1016/j.ejrad.2022.110448

Cited by 2 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Its only flaw is that it has not been studied as well as BAE to ensure its safety and success. Yang et al [73] used the dual-vessel intervention (DVI) technique. This is a less successful technique that scored technical and clinical rates of 80% and 66.7%, respectively.…”

Section: Findings Of the Studiesmentioning

confidence: 99%

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Karlafti,

Tsavdaris,

Kotzakioulafi

et al. 2023

JPM

View full text Add to dashboard Cite

Introduction: Hemoptysis is one of the most common symptoms of respiratory system diseases. Common causes include bronchiectasis, tumors, tuberculosis, aspergilloma, and cystic fibrosis. The severity of hemoptysis varies from mild to moderate to massive hemoptysis and can easily lead to hemodynamic instability and death from suffocation or shock. Nevertheless, the most threatening hemoptysis that is presented to the emergency department and requires hospitalization is the massive one. In these cases, today, the most common way to manage hemoptysis is bronchial artery embolization (BAE). Methods: A systematic literature search was conducted in PubMed and Scopus from January 2017 (with the aim of selecting the newest possible reports in the literature) until May 2023 for studies reporting massive hemoptysis. All studies that included technical and clinical success rates of hemoptysis management, as well as rebleeding and mortality rates, were included. A proportional meta-analysis was conducted using a random-effects model. Results: Of the 30 studies included in this systematic review, 26 used bronchial artery embolization as a means of treating hemoptysis, with very high levels of both technical and clinical success (greater than 73.7% and 84.2%, respectively). However, in cases where it was not possible to use bronchial artery embolization, alternative methods were used, such as dual-vessel intervention (80% technical success rate and 66.7% clinical success rate), customized endobronchial silicone blockers (92.3% technical success rate and 92.3% clinical success rate), antifibrinolytic agents (50% clinical success rate), and percutaneous transthoracic embolization (93.1% technical success rate and 88.9% clinical success rate), which all had high success rates apart from antifibrinolytic agents. Of the 2467 patients included in these studies, 341 experienced rebleeding during the follow-up period, while 354 other complications occurred, including chest discomfort, fever, dysphagia, and paresis. A total of 89 patients died after an episode of massive hemoptysis or during the follow-up period. The results of the meta-analysis showed a pooled technical success of bronchial artery embolization equal to 97.22% and a pooled clinical success equal to 92.46%. The pooled recurrence was calculated to be 21.46%, while the mortality was 3.5%. These results confirm the ability of bronchial artery embolization in the treatment of massive hemoptysis but also emphasize the high rate of recurrence following the intervention, as well as the risk of death. Conclusion: In conclusion, massive hemoptysis can be treated with great clinical and technical success using bronchial artery embolization, reducing mortality. Mortality has now been reduced to a small percentage of cases.

show abstract

Section: Findings Of the Studiesmentioning

confidence: 99%

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Karlafti,

Tsavdaris,

Kotzakioulafi

et al. 2023

JPM

View full text Add to dashboard Cite

show abstract

“…At the one-year follow-up, the recurrence rate after BAE can reach 57.5%, particularly in some instances of cavitary lesions. Cavitary lesions and aspergilloma are thought to have the highest recurrence rates (5) .…”

Section: Introductionmentioning

confidence: 99%

Role of Umbilical Cord C- Peptide Level in Early Detection of Hypoglycemia in Infant of Diabetic Mother

Assar¹,

Rachwan²,

Khalifa³

et al. 2023

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: Embolization of the bronchial artery is one of the non-surgical successful measures to treat hemoptysis without surgery. Aim of the Work:To evaluate the technique, efficacy, and safety of Bronchial Artery Embolization (BAE) in patients with hemoptysis due to cavitary lung lesions. Patients and Methods: This study was a reconstructive (retrospective and prospective) cohort study and included 20 candidates who presented with hemoptysis due to cavitary lung lesions and were refractory to the supportive treatment measures during the period between March 2021 and September 2021. The study population was referred from the Chest Department to Interventional Radiology Unit, at Ain Shams University Hospitals. Results: Massive hemoptysis was seen in 15 patients and recurrent mild-moderate in 5 patients. On imaging, cavitary lesions were seen on the left side in 8 patients, the right side in 8 patients, and bilateral involvement in 4 patients. Bronchiectatic changes were the predominant pathology seen in 6 patients. Immediate success was achieved in 20 patients, while recurrence within one month was noted in 4 patients. 13 patients reported experiencing minor problems like chest pain, but no serious ones like spinal cord ischemia. Conclusion:When a patient has hemoptysis, BAE is a standard technique that is both safe and effective with a very low complication rate.

show abstract

Dual-vessel intervention treatment for massive hemoptysis caused by lung cavitary lesions

Cited by 2 publications

References 17 publications

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Role of Umbilical Cord C- Peptide Level in Early Detection of Hypoglycemia in Infant of Diabetic Mother

Contact Info

Product

Resources

About